Wyeth Drops MedImmune FluMist Partnership, Will Transfer Clinical Data
This article was originally published in The Pink Sheet Daily
Executive Summary
MedImmune will continue developing the flu vaccine without a partner. The company has signaled that Wyeth might pull out of the partnership as a result of lower than expected revenues for the product.